Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published December 2, 2003 | public
Journal Article

Ubiquitin-Mediated Proteasome Activity Is Required for Agonist-Induced Endocytosis of GluRs

Abstract

Recent studies documenting a role for local protein synthesis in synaptic plasticity have lead to interest in the opposing process, protein degradation, as a potential regulator of synaptic function [1–7]. The ubiquitin-conjugation system identifies, modifies, and delivers proteins to the proteasome for degradation [8, 9]. We found that both the proteasome and ubiquitin are present in the soma and dendrites of hippocampal neurons. As the trafficking of glutamate receptors (GluRs) is thought to underlie some forms of synaptic plasticity [10, 11], we examined whether blocking proteasome activity affects the agonist-induced internalization of GluRs in cultured hippocampal neurons. Treatment with the glutamate agonist AMPA induced a robust internalization of GluRs. In contrast, brief pretreatment with proteasome inhibitors completely prevented the internalization of GluRs. To distinguish between a role for the proteasome and a possible diminution of the free ubiquitin pool, we expressed a chain elongation defective ubiquitin mutant (UbK48R), which causes premature termination of polyubiquitin chains but, importantly, can serve as a substrate for mono-ubiquitin-dependent processes. Expression of K48R in neurons severely diminished AMPA-induced internalization establishing a role for the proteasome. These data demonstrate the acute (e.g., minutes) regulation of synaptic function by the ubiquitin-proteasome pathway in mammalian neurons.

Additional Information

© 2003 Cell Press. Received 18 August 2003, Revised 10 October 2003, Accepted 10 October 2003, Available online 4 December 2003. We thank members of the Schuman lab and Ray Deshaies for helpful discussions. This work was supported by the Damon Runyon Walter Winchell Fund (G.N.P.) and the Mettler Caltech Autism Fund. E.M.S. is an Associate Investigator of the Howard Hughes Medical Institute.

Additional details

Created:
September 28, 2023
Modified:
October 24, 2023